Michael Byrnes - 07 Jun 2022 Form 4 Insider Report for eFFECTOR Therapeutics, Inc.

Role: Chief Financial Officer
Signature: /s/ Michael Byrnes
Issuer symbol: EFTR on OTC
Transactions as of: 07 Jun 2022
Net transactions value: +$33,262
Form type: 4
Filing time: 07 Jun 2022, 17:30:12 UTC
Previous filing: 17 May 2022
Next filing: 22 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EFTR	Common Stock	Purchase	$33,262	+25,000	+591%	$1.33	29,233	07 Jun 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.275 to $1.360. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.275 to $1.360. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.